Meg Jardine's Publications

• Canagliflozin slows progression of renal function decline independent of glycaemic effects

  Conference Papers

  2016

  DIABETOLOGIA

• Challenges in conducting clinical trials in nephrology: conclusions from a Kidney DiseaseImproving Global Outcomes (KDIGO) Controversies Conference

  Conference Papers

  2016

  Kidney International

• THE OXFORD CLASSIFICATION SYSTEM (MEST) IN IGA NEPHROPATHY (IGAN): READY FOR ROUTINE CLINICAL PRACTICE?

  Conference Papers

  2016

  NEPHROLOGY

• TRENDS IN THE RELATIVE SURVIVAL OF MIDDLE AGED AND OLDER PEOPLE ON DIALYSIS IN AUSTRALIA

  Conference Papers

  2016

  NEPHROLOGY

• TRENDS IN HAEMOGLOBIN CONCENTRATION AND ERYTHROPOIESIS STIMULATING AGENT (ESA) USE IN THE AUSTRALIAN DIALYSIS POPULATION

  Conference Papers

  2016

  NEPHROLOGY

• IS IMMUNOSUPPRESSIVE THERAPY BENEFICIAL FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY: A SYSTEMATIC REVIEW AND TRIAL SEQUENTIAL ANALYSIS OF PUBLISHED TRIALS

  Conference Papers

  2016

  NEPHROLOGY

• ASSOCIATION OF NEUROPATHY AND PHYSICAL PARAMETERS IN PEOPLE ON MAINTENANCE HAEMODIALYSIS: A PROSPECTIVE STUDY

  Conference Papers

  2016

  NEPHROLOGY

• EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS

  Conference Abstracts

  2016

  NEPHROLOGY

• Effects of the mediterranean diet on cardiovascular outcomes-a systematic review and meta-analysis

  Journal articles

  2016

  PLoS ONE

• Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF

  Journal articles

  2016

  Journal of the American College of Cardiology

• Canagliflozin (CANA) Slows Progression of Renal Function Decline Independent of Glycemic Effects

  Conference Papers

  2016

  DIABETES

• Interventions for lowering plasma homocysteine levels in dialysis patients

  Journal articles

  2016

  Cochrane Database of Systematic Reviews

• EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS

  Conference Papers

  2016

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease

  Journal articles

  2016

  Cochrane Database of Systematic Reviews

• Prediction of 10-year vascular risk in patients with diabetes: The AD-ON risk score

  Journal articles

  2016

  Diabetes, Obesity and Metabolism

• Survival outcomes of supportive care versus dialysis therapies for elderly patients with end-stage kidney disease: A systematic review and meta-analysis

  Journal articles

  2016

  Nephrology

• Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis

  Journal articles

  2016

  BMJ (Online)

• MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS

  Journal articles

  2016

  Nephrology Dialysis Transplantation

• Renal effects of canagliflozin in type 2 diabetes mellitus

  Journal articles

  2015

  Current Medical Research and Opinion

• THE SHARP-ER STUDY: DESIGN OF THE EXTENDED FOLLOW-UP OF THE SHARP STUDY COHORT

  Conference Papers

  2015

  NEPHROLOGY

• First Light after the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial

  Journal articles

  2015

  American Journal of Kidney Diseases

• Interventions for lowering plasma homocysteine levels in kidney transplant recipients

  Journal articles

  2015

  Cochrane Database of Systematic Reviews

• Design and participant baseline characteristics of A Clinical Trial of IntensiVE Dialysis: The ACTIVE Dialysis Study

  Journal articles

  2015

  Nephrology

• EFFECTS OF THE MEDITERRANEAN DIET ON CARDIOVASCULAR OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS

  Conference Papers

  2015

  JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

• Health-related quality of life in survivors of acute kidney injury: The Prolonged Outcomes Study of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy study outcomes

  Journal articles

  2015

  Nephrology

• A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial

  Journal articles

  2015

  American Journal of Kidney Diseases